基于文献计量分析的我国单病种付费模式及效果研究  

Mode and Effect of Single Disease Payment in China Based on Biliometric Analysis

作　　者：陈焱秋 张冬儿 唐文熙[1] CHEN Yan-qiu;ZHANG Dong-er;TANG Wen-xi(School of International Pharmaceutical Business,China Pharmaceutical University,Nanjing,Jiangsu,211198,China)

机构地区：[1]中国药科大学国际医药商学院

出　　处：《中国医院管理》2020年第2期5-7,共3页Chinese Hospital Management

基　　金：国家自然科学基金青年科学基金项目(71603278);中国药科大学青年教改专项(2017XJQN32);大学生创新创业训练计划项目(201910316179)

摘　　要：目的分析我国单病种付费的效果,探索完善单病种付费的方法以及向疾病诊断相关分组(DRG)过渡的条件。方法遵循系统综述流程,检索中国知网和PubMed数据库,制定纳入排除标准筛选文献,采用文献计量分析总结目前单病种付费实施的效果及问题。结果单病种付费的控费效果显著,表现为住院日、药品费用的大幅下降,但也存在付费标准科学性不高、适用范围小、限制医疗卫生技术的发展等问题。结论开发单病种临床路径智能管理系统以完善单病种付费,同时探索由单病种付费向DRG的过渡。Objective To analyze the effects of the single disease payment,and explore the methods of improving single disease payment and the conditions for the transition to DRG.Methods Through the systematic review,developing the screening criteria for inclusion and exclusion by searching CNKI and Pub Med database,and summarizing the effects and problems of the implementation of the current single disease payment by using the bibliometric analysis.Results The effect of expenses controlling of single disease payment is very obvious,which is manifested by the dramatic decrease of hospitalization days and drug costs.But there are also some problems,such as unscientific payment standard,narrow coverage and restriction on the development of new medical technology.Conclusion Intelligent management system of single disease Clinical Pathway should be developed to improve single disease payment and to explore the transition from single disease payment to DRG.

关 键 词：单病种付费 医保支付 文献计量分析 

分 类 号：R197.1[医药卫生—卫生事业管理]